Search
for
Sort by
Research 121–150 of 1000+
- Dermatological care of gender‐diverse patients in Australia
- Dermatologic therapy: December 1987 to December 1988
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- Dermatologic Signs and Symptoms of Substance Abuse
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Alopecia Neoplastica: A Manifestation of Metastatic Breast Cancer
- Dermatological Drugs, Topical Agents, and Cosmetics
- The impact of exercise on tolerability of systemic treatment in metastatic colorectal cancer: A literature review
- Brazilian blood donation eligibility criteria for dermatologic patients
- Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer
- Management of the adverse effects of targeted therapy for cancer
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Advancements in Dermatological Imaging Modalities
- Cosmetic and Dermatological Properties of Olive Oil Byproduct-Supplemented Skin and Hair Care Products
- Herbal Treatment for Dermatologic Disorders
- Women's Dermatologic Diseases, Health Care Delivery, and Socioeconomic Barriers
- Spironolactone use and the risk of breast cancer
- Skin toxicity of anti‐cancer therapy
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Correlation Between In Vivo Reflectance Confocal Microscopy and Horizontal Histopathology in Skin Cancer: A Review
- Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer
- Prevention and treatment of adverse effects related to chemotherapy for recurrent ovarian cancer
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- α‐Difluoromethylornithine, a polyamine inhibitor: its potential role in controlling hair growth and in cancer treatment and chemo‐prevention
- Bee venom: a case of effectiveness on skin varicosities veins with review of its dermatological benefits
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- 1030 EGFR protects the upper hair follicle from staphylococcus driven folliculitis